LGND : Analysis & Opinions

  1. Spectrum/Ligand Pharma Seek FDA Nod for CE-Melphalan - Analyst ...

    December 29, 2014
    Spectrum Pharmaceuticals (SPPI) submitted a new drug application to the FDA for Captisol-enabled melphalan (propylene glycol-free) ...
  2. Ride The Ups And Downs Of Drug Approval

    October 16, 2008
    The FDA's complex drug approval process provides plenty of volatility for short-term traders to feast upon.
Trading Center